Showing results (31-40 of 106) with videos related to
Sort By:
Pageof 11
Scientific Reports|July 18, 2019
A role for ABCB1 in prognosis, invasion and drug resistance in ependymomaDurgagauri H Sabnis, Lisa C D Storer, Jo-Fen Liu, et al.Molecular Cancer Therapeutics|July 21, 2010
Histone deacetylase inhibition attenuates cell growth with associated telomerase inhibition in high-grade childhood brain tumor cellsRuman Rahman, Teresa Osteso-Ibanez, Robert A Hirst, et al.Studies in Health Technology and Informatics|July 9, 2015
3D Texture Analysis of Heterogeneous MRI Data for Diagnostic Classification of Childhood Brain TumoursAhmed E Fetit, Jan Novak, Daniel Rodriguez, et al.Heliyon|January 16, 2025
Metabolomic characterisation of the glioblastoma invasive margin reveals a region-specific signatureJames Wood, Stuart J Smith, Marcos Castellanos-Uribe, et al.Acta Neuropathologica Communications|June 8, 2017
Evaluation of a novel antibody to define histone 3.3 G34R mutant brain tumoursFarhana Haque, Pascale Varlet, Julien Puntonet, et al.Acta Neuropathologica|November 24, 2011
Supratentorial and spinal pediatric ependymomas display a hypermethylated phenotype which includes the loss of tumor suppressor genes involved in the control of cell growth and deathHazel A Rogers, John-Paul Kilday, Cerys Mayne, et al.Brain Pathology (Zurich, Switzerland)|March 29, 2007
Nodule formation and desmoplasia in medulloblastomas-defining the nodular/desmoplastic variant and its biological behaviorCharles S McManamy, Jane Pears, Claire L Weston, et al.Acta Neuropathologica Communications|June 3, 2014
Overcoming multiple drug resistance mechanisms in medulloblastomaRamadhan T Othman, Ioanna Kimishi, Tracey D Bradshaw, et al.Journal of Negative Results in Biomedicine|June 2, 2011
Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohortsDavid W Ellison, Mehmet Kocak, Dominique Figarella-Branger, et al.Archives of Disease in Childhood|January 4, 2023
Can I go home now? The safety and efficacy of a new UK paediatric febrile neutropenia protocol for risk-stratified early discharge on oral antibioticsThomas John Jackson, Rachel Napper, Gabrielle M Haeusler, et al.Pageof 11